Cargando…

Test–Retest Reliability of the Impact of Vision Impairment–Very Low Vision Questionnaire

PURPOSE: Most patient-reported outcome measures used in ophthalmology show floor effects in a very low vision population, which limits their use in vision restoration trials. The Impact of Vision Impairment–Very Low Vision scale (IVI–VLV) was developed to specifically target a very low vision popula...

Descripción completa

Detalles Bibliográficos
Autores principales: Fink, David J., Terheyden, Jan H., Pondorfer, Susanne G., Holz, Frank G., Finger, Robert P.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: The Association for Research in Vision and Ophthalmology 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10266551/
https://www.ncbi.nlm.nih.gov/pubmed/37306995
http://dx.doi.org/10.1167/tvst.12.6.6
_version_ 1785058761357918208
author Fink, David J.
Terheyden, Jan H.
Pondorfer, Susanne G.
Holz, Frank G.
Finger, Robert P.
author_facet Fink, David J.
Terheyden, Jan H.
Pondorfer, Susanne G.
Holz, Frank G.
Finger, Robert P.
author_sort Fink, David J.
collection PubMed
description PURPOSE: Most patient-reported outcome measures used in ophthalmology show floor effects in a very low vision population, which limits their use in vision restoration trials. The Impact of Vision Impairment–Very Low Vision scale (IVI–VLV) was developed to specifically target a very low vision population, but its test–retest reliability has not been investigated yet. METHODS: The German version of the IVI–VLV was administered twice to patients with stable disease of a low vision clinic. Test and retest person measures of the IVI–VLV subscales were obtained from Rasch analysis. Test–retest reliability was investigated by intraclass correlation coefficients and Bland–Altman plots. RESULTS: We included 134 patients (72 women, 62 men) at a mean age of 62 ± 15 years. The intraclass correlation coefficients were 0.920 (95% confidence interval, 0.888–0.944) for the activities of daily living and mobility subscale of the IVI–VLV and 0.929 (95% confidence interval, 0.899–0.949) for the emotional well-being subscale. Bland–Altman plots did not indicate any systematic bias. In linear regression analysis, test–retest differences were not significantly associated with visual acuity or administration interval. CONCLUSIONS: Both subscales of the IVI–VLV showed excellent repeatability independent of visual acuity and length of repeat interval. Further validation steps including an assessment of the patient-reported outcome measure's responsiveness are required for use in vision restoration trials. TRANSLATIONAL RELEVANCE: The results support repeated use of the IVI–VLV as a patient-reported end point in future studies in very low and ultralow vision populations.
format Online
Article
Text
id pubmed-10266551
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher The Association for Research in Vision and Ophthalmology
record_format MEDLINE/PubMed
spelling pubmed-102665512023-06-15 Test–Retest Reliability of the Impact of Vision Impairment–Very Low Vision Questionnaire Fink, David J. Terheyden, Jan H. Pondorfer, Susanne G. Holz, Frank G. Finger, Robert P. Transl Vis Sci Technol Retina PURPOSE: Most patient-reported outcome measures used in ophthalmology show floor effects in a very low vision population, which limits their use in vision restoration trials. The Impact of Vision Impairment–Very Low Vision scale (IVI–VLV) was developed to specifically target a very low vision population, but its test–retest reliability has not been investigated yet. METHODS: The German version of the IVI–VLV was administered twice to patients with stable disease of a low vision clinic. Test and retest person measures of the IVI–VLV subscales were obtained from Rasch analysis. Test–retest reliability was investigated by intraclass correlation coefficients and Bland–Altman plots. RESULTS: We included 134 patients (72 women, 62 men) at a mean age of 62 ± 15 years. The intraclass correlation coefficients were 0.920 (95% confidence interval, 0.888–0.944) for the activities of daily living and mobility subscale of the IVI–VLV and 0.929 (95% confidence interval, 0.899–0.949) for the emotional well-being subscale. Bland–Altman plots did not indicate any systematic bias. In linear regression analysis, test–retest differences were not significantly associated with visual acuity or administration interval. CONCLUSIONS: Both subscales of the IVI–VLV showed excellent repeatability independent of visual acuity and length of repeat interval. Further validation steps including an assessment of the patient-reported outcome measure's responsiveness are required for use in vision restoration trials. TRANSLATIONAL RELEVANCE: The results support repeated use of the IVI–VLV as a patient-reported end point in future studies in very low and ultralow vision populations. The Association for Research in Vision and Ophthalmology 2023-06-12 /pmc/articles/PMC10266551/ /pubmed/37306995 http://dx.doi.org/10.1167/tvst.12.6.6 Text en Copyright 2023 The Authors https://creativecommons.org/licenses/by/4.0/This work is licensed under a Creative Commons Attribution 4.0 International License.
spellingShingle Retina
Fink, David J.
Terheyden, Jan H.
Pondorfer, Susanne G.
Holz, Frank G.
Finger, Robert P.
Test–Retest Reliability of the Impact of Vision Impairment–Very Low Vision Questionnaire
title Test–Retest Reliability of the Impact of Vision Impairment–Very Low Vision Questionnaire
title_full Test–Retest Reliability of the Impact of Vision Impairment–Very Low Vision Questionnaire
title_fullStr Test–Retest Reliability of the Impact of Vision Impairment–Very Low Vision Questionnaire
title_full_unstemmed Test–Retest Reliability of the Impact of Vision Impairment–Very Low Vision Questionnaire
title_short Test–Retest Reliability of the Impact of Vision Impairment–Very Low Vision Questionnaire
title_sort test–retest reliability of the impact of vision impairment–very low vision questionnaire
topic Retina
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10266551/
https://www.ncbi.nlm.nih.gov/pubmed/37306995
http://dx.doi.org/10.1167/tvst.12.6.6
work_keys_str_mv AT finkdavidj testretestreliabilityoftheimpactofvisionimpairmentverylowvisionquestionnaire
AT terheydenjanh testretestreliabilityoftheimpactofvisionimpairmentverylowvisionquestionnaire
AT pondorfersusanneg testretestreliabilityoftheimpactofvisionimpairmentverylowvisionquestionnaire
AT holzfrankg testretestreliabilityoftheimpactofvisionimpairmentverylowvisionquestionnaire
AT fingerrobertp testretestreliabilityoftheimpactofvisionimpairmentverylowvisionquestionnaire